Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec
et al
Ann Rheum Dis
.
2022 Aug;81(8):e138.
doi: 10.1136/annrheumdis-2020-218385.
Epub 2020 Sep 1.
Authors
Chen-Yu Wei
1
,
Yung-Heng Lee
2
3
4
5
,
James Cheng Chung Wei
6
7
Affiliations
1
School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2
Department of Health Services Administration, China Medical University, Taichung, Taiwan.
3
Department of Public Health, China Medical University, Taichung, Taiwan.
4
Department of Orthopedics, Cishan Hospital, Ministry of Health and Welfare, Kaohsiung, Taiwan.
5
Department of Center for general education, National United University, Miaoli, Taiwan.
6
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan jccwei@gmail.com.
7
Department of Medicine, Chung Shan Medical University Hospital; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
PMID:
32873556
DOI:
10.1136/annrheumdis-2020-218385
No abstract available
Keywords:
arthritis; arthritis, psoriatic; autoimmune diseases.
Publication types
Letter
Comment
MeSH terms
Arthritis, Psoriatic* / drug therapy
Humans